Live progression free from multiple myeloma longer.

For adults with Multiple Myeloma who have received at least 2 prior treatments

Going progression free longer means going longer without your Multiple Myeloma getting worse

In a clinical study, SARCLISA given with Pomalyst® (pomalidomide) and dexamethasone (Pd) extended the time people lived without their multiple myeloma getting worse compared to Pd alone (median of 11.5 months vs 6.5 months).

SARCLISA trial results

proven in a Phase 3 study.

See the Results

Target icon

SARCLISA is a targeted
immunotherapy that works
together with your
immune system.

See How It Works

Quiz icon

Answer 7 short questions
to find out if SARCLISA
could be appropriate for you.

Take a Short Quiz

Play icon


Hear stories from people who are living with relapsed refractory Multiple Myeloma or caring for someone who is.